Merck & Co.’s reported plans to cut back its workforce by about 13,000 by 2015 will not affect its local operations, Frank Gutiérrez, general manager of Merck Puerto Rico and the Caribbean, said Friday.
In an interview with News is my Business, the executive said the pharmaceutical company already completed the adjustments it needed to make in Puerto Rico, post-merger with Schering-Plough.
“At this time we’re not seeing any impact, as when the merger with Schering took place, we implemented a personnel reduction of 30 percent,” Gutiérrez said. “We were the first to make the necessary adjustments, during the first half of 2010.”
Merck currently has three local plants, in Arecibo, Barceloneta and Las Piedras, with a combined workforce of 1,500 people.
“As a matter of fact, we’re currently recruiting specialized personnel in certain areas, such as vaccines and marketing, which we’re looking to reinforce,” said Gutiérrez. “We’re actually adding, not subtracting, so our situation is stable.”
On Friday, Merck announced plans for a new round of restructuring, which would represent eliminating as many as 13,000 positions companywide. The drugmaker is bracing for competition from generic products that will go against its top-selling Singulair drug, and the ensuing slower revenue growth expected in the U.S. and Europe.
Singulair produced about $5 billion in sales last year — nearly 11 percent of the pharmaceutical company’s total revenue.
Citing Merck officials, the Associated Press reported that most of the job cuts will come from headquarters and other administrative functions. The downsizing process is expected to start next year and be completed by 2015.